| Literature DB >> 22144976 |
Preeti B Sharma1, Fuad Baroody, David Gozal, Lucille A Lester.
Abstract
BACKGROUND: Obstructive sleep apnea syndrome (OSA) is a frequent disorder in children. The clinical characteristics of OSA in very young children under 2 years of age, and more particularly, in those born prematurely, and who have respiratory complications such as bronchopulmonary dysplasia (BPD), are not well defined. We therefore retrospectively reviewed our experience in a group of preterm infants with OSAS.Entities:
Keywords: lung disease; obstructive sleep apnea; premature infant; tonsillectomy
Year: 2011 PMID: 22144976 PMCID: PMC3226060 DOI: 10.3389/fneur.2011.00073
Source DB: PubMed Journal: Front Neurol ISSN: 1664-2295 Impact factor: 4.003
Patient demographic data.
| No. | GA (weeks) | BW (g) | Time w/ETT (days) | Medical problems | Age at presentation (months) | Major presenting signs |
|---|---|---|---|---|---|---|
| 1 | 27 | 1,100 | 7 | BPD | 10 | ALTE, supplemental oxygen |
| 2 | 27 | 962 | 86 | BPD,IVH, CP | 28 | Snoring, FTT |
| 3 | 24 | 733 | 60 | BPD, IVH, seizure | 15 | ALTE, FTT |
| 4 | 24 | 890 | 91 | BPD, PVL, seizure | 20 | Inability to extubate |
| 5 | 29 | 814 | 30 | BPD, IVH | 13 | Snoring |
| 6 | 25 | 680 | 90 | BPD | 22 | Snoring, supplemental oxygen, FTT |
| 7 | 24 | 622 | 93 | BPD | 22 | Snoring, supplemental oxygen, FTT |
| 8 | 28 | 1,220 | 12 | BPD | 33 | Snoring |
| 9 | 29 | 1,775 | 3 | None | 9 | Snoring, supplemental oxygen |
| 10 | 29 | 1,410 | 0 | None | 18 | Snoring |
| 11 | 33 | Unknown | 0 | None | 15 | Snoring |
| 12 | 26 | Unknown | 60 | BPD | 15 | FTT, supplemental oxygen |
BPD, bronchopulmonary dysplasia; IVH, intraventricular hemorrhage; CP, cerebral palsy; PVL, periventricular leukomalacia; ALTE, acute life threatening event; FTT, failure to thrive; GA, gestational age; BW, birth weight; ETT, endotracheal tube.
Polysomnography results and treatment outcomes.
| Age at PSG (months) | Total sleep time (min) | Central apneas ( | Obstructive apneas ( | Hypopnea events ( | AHI (/h TST) | SpO2 nadir | Intervention | Follow-up PSG (AHI) | |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 9 | 362 | 0 | 325 | 108 | 72 | 50% | AT then tracheostomy | None |
| 2 | 28 | 412 | 24 | 80 | 15 | 86% | AT | None | |
| 3 | 21 | 323 | 2 | 0 | 1 | 1 | 87% | AT | 1 |
| 4 | None | AT | None | ||||||
| 5 | 12 | 374 | 6 | 0 | 35 | 7 | 92% | AT | 2 |
| 6 | 25 | 391 | 0 | 0 | 44 | 7 | 83% | AT | None |
| 7 | 22 | 157 | 2 | 0 | 67 | 26 | 72% | AT | None |
| 8 | None | AT | None | ||||||
| 9 | 9 | 343 | 2 | 138 | 84 | 38 | 46% | AT, CPAP | 23 |
| 10 | 30 | 374 | 1 | 3 | 60 | 20 | 88% | AT | 16 |
| 11 | 16 | 351 | 1 | 503 | 188 | 120 | 74% | AT, supplemental oxygen | 6 |
| 12 | 17 | 322 | 4 | 32 | 164 | 39 | 81% | AT | None |
PSG, polysomnography; AHI, apnea–hypopnea index; RDI, respiratory disturbance index; SpO.